Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs for Erectile Dysfunction in Type 1 Diabetes
NCT03361631Phase 1Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jun 2018
- Primary completion
- Jul 2018
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label, single-arm trial of autologous bone marrow derived mesenchymal stromal cells in erectile dysfunction (ED), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Occurrence of clinical adverse event at 2 weeks. Status: unknown.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03361631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03361631.